glp-1 medical weight loss bentonville Semaglutide FDA Weightloss Approval GLP-1 Weight Loss Specialist in

People who use Zepbound or Mounjaro, the dual-agonist medications, lose an average of about 20% of their body weight, while those who take Ozempic or Wegovy, the single-agonist drugs, lost an average of about 14% of their body weight

The REWIND trial demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors

The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 49 peptides to reveal how your body processes GLP-1 compounds and glucose-regulating hormones

Off-label uses or unregulated supplements may carry additional safety, quality, and effectiveness risks